Achieve Life Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $10.7M | $7.6M |
| FY2009 | — | $23.0M | $62.1M |
| FY2010 | — | $44.1M | $23.5M |
| FY2011 | — | $30.9M | $28.5M |
| FY2012 | — | $66.2M | $18.1M |
| FY2013 | — | $37.2M | $14.6M |
| FY2014 | — | $34.1M | $27.9M |
| FY2015 | — | $0 | $34.3M |
| FY2016 | — | $610.0K | $15.0K |
| FY2017 | — | $15.8M | $5.3M |
| FY2018 | — | $15.8M | $9.5M |
| FY2019 | — | $18.1M | $16.7M |
| FY2020 | — | $37.3M | $35.9M |
| FY2021 | — | $28.0M | $43.0M |
| FY2022 | — | $8.3M | $24.8M |
| FY2023 | — | $-1.4M | $15.5M |
| FY2024 | — | $20.9M | $12.8M |
| FY2025 | — | $21.5M | $20.9M |